Brenda Chyla
Brenda Chyla publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #81,640 of 7,710,434 ranked researchers
- Rank in United States
- #31,509 of 1,627,098
- Works
- 181
- Citations
- 12k
- Citations per work
- 67.3
What does Brenda Chyla research?
Brenda Chyla's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11563.3%
- Medicine11563.3%
- Life Sciences3418.6%
- Everything else3318.1%
- 1Hematology24% of their works
- 2Genetics22% of their works
- 3Molecular Biology12% of their works
- 4Pathology and Forensic Medicine10% of their works
- 5Oncology7% of their works
- 6Immunology6% of their works
Research topics
Which keywords describe Brenda Chyla's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Acute Myeloid Leukemia, AML, Classification and Lymphoma.
- PROTACs
- JAK2 Mutation
- CDK4/6 Inhibitors
- Imatinib
- BCR-ABL
- Lymphoma
- Acute Myeloid Leukemia
- Genomic Aberrations
- Rituximab
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- AML
- Classification
- Acute Lymphoblastic Leukemia
- Childhood Cancer
- Breast Cancer
- BET Bromodomains
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors1533 topics
- Rituximab1122 topics
- Chronic Lymphocytic Leukemia741 topic
- Genomic Aberrations741 topic
- AML541 topic
- Acute Myeloid Leukemia541 topic
- Classification381 topic
- Lymphoma381 topic
- Acute Lymphoblastic Leukemia251 topic
- BCR-ABL251 topic
- Childhood Cancer251 topic
- Imatinib251 topic
- Breast Cancer161 topic
- CDK4/6 Inhibitors161 topic
- BET Bromodomains141 topic
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- PROTACs141 topic
Where does Brenda Chyla work?
Brenda Chyla's main affiliation in the publication record is AbbVie (United States), United States.
How many publications and citations does Brenda Chyla have?
OpenAlex counts 181 works and 12,182 citations for Brenda Chyla, an h-index of 43, ranking #81,640 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Brenda Chyla. Posts are plain text and can be reported.